Logo image of ABP

ABPRO HOLDINGS INC (ABP) Stock Price, Quote, News and Overview

NASDAQ:ABP - Nasdaq - US0008471031 - Common Stock - Currency: USD

0.837  -0.1 (-10.96%)

After market: 0.8436 +0.01 (+0.79%)

ABP Quote, Performance and Key Statistics

ABPRO HOLDINGS INC

NASDAQ:ABP (2/21/2025, 8:00:00 PM)

After market: 0.8436 +0.01 (+0.79%)

0.837

-0.1 (-10.96%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap42.30M
Shares50.54M
Float0
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO01-14 2022-01-14


ABP short term performance overview.The bars show the price performance of ABP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

ABP long term performance overview.The bars show the price performance of ABP in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ABP is 0.837 USD. In the past month the price decreased by -34.61%.

ABPRO HOLDINGS INC / ABP Daily stock chart

About ABP

Company Profile

ABP logo image ABPRO Holdings Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. The company went IPO on 2022-01-14. Abpro Holdings, Inc. is a biotechnology company dedicated to developing next-generation antibody therapeutics, which helps in improving the lives of patients with severe and life-threatening diseases. The firm is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its DiversImmune and MultiMab antibody discovery and engineering platforms, it is engaged in developing a pipeline of antibodies, both independently and through collaborations with global pharmaceutical and research institutions. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting human epidermal growth factor receptor 2 (HER2), and cluster of differentiation 3 (CD3), T-cell co-receptor.

Company Info

ABPRO HOLDINGS INC

6 St Johns Lane, Floor 5

New York City NEW YORK US

Employees: 0

Company Website: https://atlantic-coastal.com/

Phone: 12488907200

ABPRO HOLDINGS INC / ABP FAQ

What is the stock price of ABPRO HOLDINGS INC today?

The current stock price of ABP is 0.837 USD. The price decreased by -10.96% in the last trading session.


What is the ticker symbol for ABPRO HOLDINGS INC stock?

The exchange symbol of ABPRO HOLDINGS INC is ABP and it is listed on the Nasdaq exchange.


On which exchange is ABP stock listed?

ABP stock is listed on the Nasdaq exchange.


What is ABPRO HOLDINGS INC worth?

ABPRO HOLDINGS INC (ABP) has a market capitalization of 42.30M USD. This makes ABP a Nano Cap stock.


How many employees does ABPRO HOLDINGS INC have?

ABPRO HOLDINGS INC (ABP) currently has 0 employees.


Should I buy ABPRO HOLDINGS INC (ABP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ABPRO HOLDINGS INC (ABP) stock pay dividends?

ABP does not pay a dividend.


What is the Price/Earnings (PE) ratio of ABPRO HOLDINGS INC (ABP)?

ABPRO HOLDINGS INC (ABP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).


ABP Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ABP Financial Highlights

Over the last trailing twelve months ABP reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -292.63% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -259.7%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-915.2%
Sales Q2Q%N/A
EPS 1Y (TTM)-292.63%
Revenue 1Y (TTM)N/A

ABP Ownership and Analysts


Ownership
Inst Owners7.1%
Ins Owners3.06%
Short Float %N/A
Short Ratio0.16
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A